Cross-referencing clinical data
A pairing appears on this page only when a trial gave both ingredients together and measured the result. Agave Nectar has none that clears that bar.
Stitching two separate single-ingredient studies into a pairing is the one thing this engine will not do. When a study of the combination itself holds up at source, it lands here with its citation.
No invented synergy. Where actives were studied on their own rather than together, the record shows each on its own evidence, never a combined effect no trial measured.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
20 pairings are live across the library today. Checked 20 July 2026.
No study gave these as a pair, so they are not in the card above. But the reason they belong together is settled biochemistry, not a guess, so it is worth knowing.
The agave plant stores its carbohydrate as fructans built on beta-2,1 and beta-2,6 linked fructose chains, the same chemical family as chicory inulin. Human digestive enzymes do not cleave those linkages, so intact fructans reach the colon. Agave fructans branch more than chicory inulin, which changes how quickly different bacteria ferment them. Note that finished agave nectar has had most of these fructans hydrolysed to free fructose.
Short-chain fructans in agave overlap directly with commercial FOS in structure and chain length. Both are fermented in the proximal colon and both produce short-chain fatty acids as end products. Combining them mostly changes the chain-length distribution rather than adding a new mechanism, and the gas and bloating burden adds up across sources.
Bifidobacteria carry beta-fructofuranosidases that let them use fructans that the host cannot digest. Pairing an agave-derived fructan with a bifidobacterial strain supplies substrate alongside the organism. This is a substrate-and-organism pairing; whether the strain establishes depends on far more than substrate availability.
Some lactobacilli ferment short-chain fructans, though the capacity is strain-specific and less consistent than in bifidobacteria. Formulators pair the two to give the delivered organism something to work with on arrival. Strain-level fermentation data should be checked rather than assumed.
Fructan fermentation lowers colonic pH and increases the soluble fraction of minerals, and rodent studies with agave fructans report higher apparent calcium absorption. Human data on this specific fructan source are thin. This is a marker of absorption in animals, not a demonstrated change in any human outcome.
The lowered luminal pH that follows fructan fermentation increases solubility of divalent minerals generally, magnesium included. The evidence base sits mostly in rodents and in inulin rather than in agave specifically. Read it as a plausible extension rather than a measured effect for this ingredient.
Agave nectar is marketed as a low glycaemic index sweetener because most of its sugar is fructose, which produces a small immediate blood glucose rise. That low index reflects where the sugar is metabolised, not a lower sugar load, since fructose is handled in the liver. Putting it in a formulation aimed at blood sugar support works against the intent regardless of what the index number says.
Nothing specific on file for Agave Nectar. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.